Tuesday, January 26, 2021
Home Latest Pharma-News

Latest Pharma-News

Merck’s VERQUVO Approved for Cardiovascular Death and Heart Failure

January 20, 2021: "Merck, known as MSD outside the United States and Canada, today announced that the U.S. FDA has approved VERQUVO,...

NHS patients to benefit from first full access deal in Europe for new CAR-T therapy recommended by NICE

January 19, 2021: "NHS patients are to be among the first in the world to be offered access to a cutting-edge cancer...

Enhertu approved in EU for HER2-positive metastatic breast cancer

January 20, 2021: "AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the European Union (EU)...

ViiV Healthcare and Chelsea and Westminster Hospital continues HIV care parternership

January 18, 2021: "ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust are continuing their innovative partnership to transform HIV patient...

More than 4 million people receive first dose of COVID-19 vaccine in UK

January 19, 2021: "More than 4 million people in the UK have received their first dose of a COVID-19 vaccine as part...

Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa

January 19, 2021: "Novartis and GSK today announced the launch of a collaboration to support high-quality scientific research investigating the link between...

Scientists tackle vaccine safety, efficacy and access at global R&D forum

January 16, 2021: "More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the...

Pfizer’s Xalkori® approved by FDA for alk-positive anaplastic lymphoma

January 14, 2021: "Pfizer Inc. announced that the U.S.FDA approved the supplemental New Drug Application (sNDA) for XALKORI® (crizotinib) for the treatment of pediatric...

GSK presents positive efficacy data of dostarlimab at ASCO Gastrointestinal Cancers Symposium

January 16, 2021: "GlaxoSmithKline (GSK) plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient (dMMR) non-endometrial advanced solid...

Bharat Biotech signs agreement with Precisa Medicamentos for supply of ‘COVAXIN™’ to Brazil

January 12, 2020: "Bharat Biotech announced that it has signed an agreement with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil.

Boehringer Ingelheim and Enara Bio join forces to discover Cancer Immunotherapies

January 12th, 2021: Boehringer Ingelheim and Enara Bio announced that they have entered into a strategic collaboration and licensing agreement to research...

Novartis ligelizumab receives FDA Breakthrough Therapy designation for CSU

Jan 14, 2021: "Novartis announced that the U.S. Food and Drug Administration (FDA) has granted ligelizumab (QGE031) Breakthrough Therapy designation for the...

Most Read

AZ’s Symbicort Turbuhaler approved as an anti-inflammatory reliever in mild asthma

January 26, 2021: "AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to...

Calquence approved in Japan for the treatment of relapsed or refractory chronic lymphocytic leukaemia

January 25, 2021: "AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult...

What is the process for Submission of Synopsis?

1.1 a. "Prior to submission of a thesis synopsis, a comprehensive assessment of the research work should be carried out by a...

COVAX Announces new agreement, plans for first deliveries

January 22, 2021: COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income...